Lars Fruergaard Jørgensen.

President and chief executive officer (CEO)
Pathology
Novonordiskk
Montenegro

Business Expert Pharmaceutical Sciences
Biography

Lars Fruergaard Jørgensen joined Novo Nordisk in 1991 as an economist in Health Care, Economy & Planning and has over the years completed overseas postings in the Netherlands, the US and Japan. In 2004 he was appointed senior vice president for IT & Corporate Development. In January 2013 he was appointed executive vice president and chief information officer assuming responsibility for IT, Quality & Corporate Development. In November 2014 he took over the responsibilities for Corporate People & Organisation and Business Assurance and became chief of staff. Mr Jørgensen was appointed president and chief executive officer in January 2017. Mr Jørgensen has an MSc in Finance and Business Administration from Aarhus School of Business, Aarhus University, Denmark, from 1991. Mr Jørgensen is a Danish national, born November 1966.   Lars Fruergaard Jørgensen joined Novo Nordisk in 1991 as an economist in Health Care, Economy & Planning and has over the years completed overseas postings in the Netherlands, the US and Japan. In 2004 he was appointed senior vice president for IT & Corporate Development. In January 2013 he was appointed executive vice president and chief information officer assuming responsibility for IT, Quality & Corporate Development. In November 2014 he took over the responsibilities for Corporate People & Organisation and Business Assurance and became chief of staff. Mr Jørgensen was appointed president and chief executive officer in January 2017. Mr Jørgensen has an MSc in Finance and Business Administration from Aarhus School of Business, Aarhus University, Denmark, from 1991. Mr Jørgensen is a Danish national, born November 1966.  

Research Intrest

Pathology

Global Scientific Words in Pharmaceutical Sciences